• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

UMass Chan Medical School and Curai Health Partner to Provide Virtual Care for COVID-19 and Flu Study Participants

by Fred Pennic 02/24/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– UMass Chan Medical School and Curai Health, a provider of virtual care solutions, today announced a partnership to provide free virtual care visits to participants enrolled in the STOP COVID-19 research study. 

– The collaboration aims to enhance access to care for individuals who test positive for COVID-19 or influenza and contribute to a better understanding of home-based testing for these viruses.

STOP COVID-19 Study

The STOP COVID-19 study, funded by the National Institutes of Health, is investigating the performance of rapid antigen tests compared to PCR tests in detecting COVID-19 after the onset of symptoms. Participants in the study who test positive for COVID-19 or the flu will now have access to Curai Health’s virtual care platform, where they can connect with licensed clinicians for diagnosis, treatment, and management of their condition.

Through this partnership, study participants will have access to:

  • Free virtual care visits: Connect with licensed clinicians for diagnosis and management of COVID-19, influenza, and other medical needs.
  • Convenient and accessible care: Receive care from the comfort of their own homes, eliminating the need for travel to a clinic or hospital.
  • Personalized treatment plans: Benefit from AI-powered insights and personalized treatment recommendations.

“Improving at-home testing for COVID-19 is an important first step, but it needs to be paired with getting clinical care because these respiratory viruses still cause significant disease and deaths. Rapid access to a clinician that can prescribe the appropriate treatment is necessary but often hard for patients, especially if they are self-isolating,” said Apurv Soni, MD, PhD’21, assistant professor of medicine and co-director of the Program in Digital Medicine at UMass Chan Medical School. Dr. Soni is the study’s principal investigator. “With Curai, our participants will have the option to either seek care on their own or instantaneously receive quality virtual care from the safety and convenience of their home.”  

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Coronavirus (COVID-19)

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

HIMSS26 Wrap-Up

HIMSS26 Wednesday Wrap-Up: Scaling Agentic AI, Securing the Enterprise, and Fixing Hospital Finance

Most-Read

Health Recovery Solutions (HRS) Acquires Rimidi for Chronic Care Management and RPM Integration

Health Recovery Solutions (HRS) Acquires Rimidi for Chronic Care Management and RPM Integration

RadNet Subsidiary DeepHealth Acquires French Radiology AI Leader Gleamer

RadNet’s $269M AI Play: DeepHealth Acquires French AI Gleamer

Walgreens Launches Virtual Weight Management Platform for Self-Pay GLP-1 Patients

Walgreens Launches Virtual Weight Management Platform for Self-Pay GLP-1 Patients

KLAS Digital Pathology 2026 Report: Top IMS, Scanner, and AI Vendors Evaluated

KLAS Digital Pathology 2026 Report: Top IMS, Scanner, and AI Vendors Evaluated

The "Platform" Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

The “Platform” Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

Analysis: Oracle Cerner’s Plans for a National EHR

Oracle May Cut 30k Jobs and Sell Cerner to Fund $156B OpenAI Deal

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |